Pricing
Choose how we work together.
Choose the depth that fits the problem. A two-week diagnostic can stand alone or lead into a growth partnership if the plan is worth executing together. Monthly partnerships have no annual lock-in.
Diagnostic
$2,500
one-time
Two-week review of your paid accounts, landing pages, offer, checkout, and measurement. You get a written report, a 60-min walkthrough, and a 90-day plan you can run with us or in-house.
- Paid account teardown
- Landing page, PDP, and checkout teardown
- Measurement and attribution audit
- Blended CAC, MER, and margin view
- Prioritized 90-day roadmap
- 60-min strategy walkthrough
- Written report you keep
Growth Partner
$12,000
/ month
We work inside your team each week to improve paid ads, conversion, and measurement. Monthly, no annual lock-in.
- Paid ads management
- Creative testing cadence
- Conversion test roadmap
- Measurement and budget reviews
- Async support and two weekly calls
- Quarterly strategy review
Project
from $8,000
scope-based
One focused growth problem fixed properly. PDP rebuild, paid-launch sprint, attribution overhaul, landing-page redesign. Scoped per engagement.
- Defined scope and deliverables
- Fixed timeline (4–8 weeks typical)
- Direct work, no account-manager layer
- Hand-off documentation
FAQ
- Why no annual contract?
- If we're not earning the renewal monthly, you shouldn't be locked in. Annual deals make sense for the agency, not the client. Pause or stop any month with two weeks' notice.
- Do you take equity?
- Not as the standard offer. The core offer is a cash diagnostic, project, or monthly partnership. Any different structure would be discussed after the diagnostic.
- When is this not a fit?
- This is not built for pre-revenue brands, brands without repeat buyers, or teams looking for task-only execution. We work best with operators who want a senior partner in the decisions.
- How fast can we start?
- Start timing depends on the current roster. Growth Partner work is limited to two clients a quarter, and two seats are open for Q3 2026.